Dr. Richard S. Matulewicz, MD, MS

Dr. Matulewicz practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Matulewicz's NPI, 1982965869, was assigned on June 6, 2012. Dr. Matulewicz graduated from Tufts University School Of Medicine in 2012. Dr. Matulewicz's New York license number on file is 293432.

Dr. Matulewicz's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Matulewicz's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dr. Matulewicz is also affiliated with Tisch Hospital. The medical group on file is Memorial Sloan Kettering Cancer Center at Basking Ridge New Jersey. Dmand AI also links Dr. Matulewicz to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Matulewicz practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Matulewicz's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Matulewicz is board certified in urology by the American Board of Urology. Dmand AI has Dr. Matulewicz's licenses on file in 6 states: New York, Florida, New Jersey, Pennsylvania, Connecticut and Illinois.

Dmand AI lists bladder removal, enlarged prostate, kidney cysts, kidney removal surgery, kidney stones, prostate cancer, prostate surgery and urinary endoscopy among the conditions Dr. Matulewicz treats.

CMS data shows 376 Medicare services from Dr. Matulewicz across 8 procedure codes in 2024, for 230 Medicare patients. Medicare paid $33,348 for them. Every service was in an office.

CMS counts 230 Medicare patients who saw Dr. Matulewicz in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Matulewicz's median patient age at 71, with 12% women.

In 2024, Dr. Matulewicz wrote 12 Medicare Part D claims. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Matulewicz for performance year 2024, reported as part of a group. Dr. Matulewicz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Matulewicz as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 112 papers to Dr. Matulewicz, published from 2013 to 2025. 2021 was the busiest year, with 18. The most frequent topics are Urinary Bladder Neoplasms, Smoking Cessation and Smoking. Dr. Matulewicz has published most often in J Urol. Dr. Matulewicz's most frequent co-authors are Marc Andrew Bjurlin, DO, Scott Eliot Sherman, MD and Joel Sheinfeld, MD.

CMS Open Payments shows 5 general payments to Dr. Matulewicz from 3 drug and device companies from 2024 to 2025. Honoraria make up the largest share, 53% of the total. Cook Medical LLC paid the most, $400.

Dmand AI lists 8 awards for Dr. Matulewicz, most recently Research Scholar Award in 2021. Dr. Matulewicz serves on AUA Data Commitee.

Dr. Matulewicz graduated from Tufts University School Of Medicine in 2012. Dr. Matulewicz is a member of AOA.

Dr. Matulewicz is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.